To further promote academic exchange in the field of infectious diseases and liver diseases, enhance the diagnosis and treatment capabilities for infection-related liver injuries and drug-induced liver disease (DILI), and share the latest research findings and clinical practice guidelines, the "Academic Conference on Infections and Drug-Induced Liver Disease," organized by the Chengdu High-Tech Zone Medical Association, was scheduled to take place from January to December 2026 in a hybrid online and offline format.

The conference aimed to establish a communication platform integrating cutting-edge research, clinical practice, and multidisciplinary perspectives. It delved into the translational pathways from molecular mechanisms to bedside applications, analyzed the intrinsic patterns of synergistic effects between various infectious factors and drug toxicity, and shared experiences and reflections on the diagnosis and treatment of complex cases. The event sought to foster consensus on early warning, precise diagnosis, and individualized management of related liver diseases, optimize and implement diagnostic and treatment standards, and ultimately achieve mutual enhancement of theoretical understanding and clinical efficacy. Through interdisciplinary collaboration and innovation, it aimed to benefit more patients.